Charles Liebow - Publications

Affiliations: 
State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Oncology, Animal Physiology Biology, Medical Biophysics

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Kamer AR, Sacks PG, Vladutiu A, Liebow C. EGF mediates multiple signals: dependence on the conditions. International Journal of Molecular Medicine. 13: 143-7. PMID 14654986 DOI: 10.3892/Ijmm.13.1.143  0.319
2002 Krebs LJ, Wang X, Nagy A, Schally AV, Prasad PN, Liebow C. Bombesin and epidermal growth factor potentiate the effect of cytotoxic LH-RH analog AN-152 in vitro. International Journal of Oncology. 21: 1325-9. PMID 12429984 DOI: 10.3892/Ijo.21.6.1325  0.762
2002 Krebs LJ, Wang X, Nagy A, Schally AV, Prasad PN, Liebow C. A conjugate of doxorubicin and an analog of Luteinizing Hormone-Releasing Hormone shows increased efficacy against oral and laryngeal cancers. Oral Oncology. 38: 657-663. PMID 12353491 DOI: 10.1016/S1368-8375(01)00130-0  0.764
2002 Huang YT, Hwang JJ, Lee LT, Liebow C, Lee PP, Ke FC, Lo TB, Schally AV, Lee MT. Inhibitory effects of a luteinizing hormone-releasing hormone agonist on basal and epidermal growth factor-induced cell proliferation and metastasis-associated properties in human epidermoid carcinoma A431 cells. International Journal of Cancer. Journal International Du Cancer. 99: 505-13. PMID 11992539 DOI: 10.1002/Ijc.10373  0.401
2002 Bergey EJ, Levy L, Wang X, Krebs LJ, Lal M, Kim KS, Pakatchi S, Liebow C, Prasad PN. DC magnetic field induced magnetocytolysis of cancer cells targeted by LH-RH magnetic nanoparticles in vitro Biomedical Microdevices. 4: 293-299. DOI: 10.1023/A:1020906307053  0.726
2001 Wang X, Pudavar HE, Kapoor R, Krebs LJ, Bergey EJ, Liebow C, Prasad PN, Nagy A, Schally AV. Studies on the mechanism of action of a targeted chemotherapeutic drug in living cancer cells by two photon laser scanning microspectrofluorometry. Journal of Biomedical Optics. 6: 319-25. PMID 11516322 DOI: 10.1117/1.1385511  0.746
2001 Bergey EJ, Wang XP, Krebs LJ, Pudavar HE, Kapoor R, Friend C, Liebow C, Prasad PN. Multicolored two-photon fluorescent microscopy and localized two-photon fluorescent spectroscopy in living cells Proceedings of Spie - the International Society For Optical Engineering. 4262: 82-88. DOI: 10.1117/12.424539  0.716
2000 Krebs LJ, Wang X, Pudavar HE, Bergey EJ, Schally AV, Nagy A, Prasad PN, Liebow C. Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor. Cancer Research. 60: 4194-9. PMID 10945629  0.757
1999 Kamer AR, Krebs L, Hoghooghi SA, Liebow C. Proliferative and apoptotic responses in cancers with special reference to oral cancers Critical Reviews in Oral Biology and Medicine. 10: 58-78. PMID 10759427 DOI: 10.1177/10454411990100010301  0.441
1999 Wang X, Krebs LJ, Al-Nuri M, Pudavar HE, Ghosal S, Liebow C, Nagy AA, Schally AV, Prasad PN. A chemically labeled cytotoxic agent: two-photon fluorophore for optical tracking of cellular pathway in chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. 96: 11081-4. PMID 10500132 DOI: 10.1073/Pnas.96.20.11081  0.746
1998 Kamer AR, Hoghooghi SA, Liebow C. Epidermal growth factor downregulates the expression of SH-PTP2 International Journal of Molecular Medicine. 1: 735-739. PMID 9852290 DOI: 10.3892/Ijmm.1.4.735  0.343
1997 Kingsbury JS, Cecere W, Mang TS, Liebow C. Photodynamic therapy for premalignant lesions in DMBA-treated hamsters: a preliminary study. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. 55: 376-81; discussion 3. PMID 9120701 DOI: 10.1016/S0278-2391(97)90130-0  0.305
1996 Kozacko MF, Mang TS, Schally AV, Priore RL, Liebow C. Bombesin antagonist prevents CO2 laser-induced promotion of oral cancer Proceedings of the National Academy of Sciences of the United States of America. 93: 2953-2957. PMID 8610149 DOI: 10.1073/Pnas.93.7.2953  0.399
1995 Crean DH, Liebow C, Lee MT, Kamer AR, Schally AV, Mang TS. Alterations in receptor-mediated kinases and phosphatases during carcinogenesis Journal of Cancer Research and Clinical Oncology. 121: 141-149. PMID 7713985 DOI: 10.1007/Bf01198095  0.421
1994 Liebow C, Crean DH, Lee MT, Kamer AR, Mang TS, Schally AV. Synergistic effects of bombesin and epidermal growth factor on cancers Proceedings of the National Academy of Sciences of the United States of America. 91: 3804-3808. PMID 8170991 DOI: 10.1073/Pnas.91.9.3804  0.387
1994 Buscail L, Delesque N, Estève JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV, Vaysse N, Susini C. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2 Proceedings of the National Academy of Sciences of the United States of America. 91: 2315-2319. PMID 7907795 DOI: 10.1073/Pnas.91.6.2315  0.448
1993 Mang TS, McGinnis C, Liebow C, Nseyo UO, Crean DH, Dougherty TJ. Fluorescence detection of tumors: Early diagnosis of microscopic lesions in preclinical studies Cancer. 71: 269-276. PMID 8416725 DOI: 10.1002/1097-0142(19930101)71:1<269::Aid-Cncr2820710141>3.0.Co;2-R  0.312
1993 Crean DH, Liebow C, Penetrante RB, Mang TS. Evaluation of porfimer sodium fluorescence for measuring tissue transformation Cancer. 72: 3068-3077. PMID 8106141 DOI: 10.1002/1097-0142(19931115)72:10<3068::Aid-Cncr2820721032>3.0.Co;2-J  0.333
1993 Liebow C, Crean DH, Schally AV, Mang TS. Peptide analogues alter the progression of premalignant lesions, as measured by Photofrin fluorescence Proceedings of the National Academy of Sciences of the United States of America. 90: 1897-1901. PMID 8095335 DOI: 10.1073/Pnas.90.5.1897  0.349
1992 Liebow C, Kamer AR. Receptor phosphatases and cancer: Models for the therapeutic. Efficacy of somatostatin and LHRH analogues Cancer Journal. 5: 200-207.  0.37
1991 Rothman S, Liebow C, Grendell J. Nonparallel transport and mechanisms of secretion Bba - Reviews On Biomembranes. 1071: 159-173. PMID 1854794 DOI: 10.1016/0304-4157(91)90023-P  0.345
1991 Liebow C, Lee MT, Kamer AR, Schally AV. Regulation of luteinizing hormone-releasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation. Proceedings of the National Academy of Sciences of the United States of America. 88: 2244-8. PMID 1672452 DOI: 10.1073/Pnas.88.6.2244  0.425
1991 Lee MT, Liebow C, Kamer AR, Schally AV. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors Proceedings of the National Academy of Sciences of the United States of America. 88: 1656-1660. PMID 1672042 DOI: 10.1073/Pnas.88.5.1656  0.502
1989 Liebow C, Reilly C, Serrano M, Schally AV. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase Proceedings of the National Academy of Sciences of the United States of America. 86: 2003-2007. PMID 2564678 DOI: 10.1073/Pnas.86.6.2003  0.46
1986 Liebow C. About the National Pancreatic Cancer Program of the NCI International Journal of Pancreatology. 1: 156-158. DOI: 10.1007/Bf02788448  0.308
1985 Hierowski MT, Liebow C, du Sapin K, Schally AV. Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line Febs Letters. 179: 252-256. PMID 2857131 DOI: 10.1016/0014-5793(85)80529-9  0.435
Show low-probability matches.